Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

raymond-james-initiates-milestone-pharmaceuticals-stock-coverage-with-strong-buy

Raymond James initiates Milestone Pharmaceuticals stock coverage with Strong Buy

Apr 11, 2026

Raymond James initiates Milestone Pharmaceuticals stock coverage with Strong Buy

Read more
eli-lilly-(lly)-analyst-ratings-data:-april-2026-updates

Eli Lilly (LLY) Analyst Ratings Data: April 2026 Updates

Apr 11, 2026

Please enable cookies. You are unable to access gurufocus.com Why have I been blocked? This website is using…

Read more
lbrx-upgraded-to-buy-by-craig-hallum-on-april-10,-2026

LBRX Upgraded to Buy by Craig-Hallum on April 10, 2026

Apr 11, 2026

Wall Street just gave LB Pharmaceuticals Inc Common Stock (LBRX) a fresh vote of confidence. Craig-Hallum initiated coverage…

Read more
cbz:-today’s-analyst-rating-data-reveals-coverage-initiated

CBZ: Today’s Analyst Rating Data Reveals Coverage Initiated

Apr 10, 2026

Please enable cookies. You are unable to access gurufocus.com Why have I been blocked? This website is using…

Read more
today’s-analyst-ratings-for-pkg:-ubs-lowers-price-target-to-$225.00

Today’s Analyst Ratings for PKG: UBS Lowers Price Target to $225.00

Apr 10, 2026

Please enable cookies. You are unable to access gurufocus.com Why have I been blocked? This website is using…

Read more
today’s-analyst-ratings-update-for-ip:-international-paper

Today’s Analyst Ratings Update for IP: International Paper

Apr 10, 2026

Please enable cookies. You are unable to access gurufocus.com Why have I been blocked? This website is using…

Read more
today’s-analyst-ratings-for-mstr:-key-updates-and-price-adjustments

Today’s Analyst Ratings for MSTR: Key Updates and Price Adjustments

Apr 10, 2026

Please enable cookies. You are unable to access gurufocus.com Why have I been blocked? This website is using…

Read more
nebius-(nbis)-stock-hits-all-time-high-after-acquisition-talks-and-new-analyst-coverage

Nebius (NBIS) Stock Hits All-Time High After Acquisition Talks and New Analyst Coverage

Apr 10, 2026

TLDR Nebius Group (NBIS) hit an all-time high of $141.14 this week, up 21.1% from the prior Friday’s…

Read more
eli-lilly-(lly)-analyst-ratings-data:-april-2026-updates

Eli Lilly (LLY) Analyst Ratings Data: April 2026 Updates

Apr 10, 2026

Please enable cookies. You are unable to access gurufocus.com Why have I been blocked? This website is using…

Read more
amgen-(amgn)-analyst-ratings-update:-price-target-raised-by-morgan-stanley

Amgen (AMGN) Analyst Ratings Update: Price Target Raised by Morgan Stanley

Apr 10, 2026

Please enable cookies. You are unable to access gurufocus.com Why have I been blocked? This website is using…

Read more
bridgebio-pharma-(bbio)-receives-positive-analyst-coverage-from-rbc-capital

BridgeBio Pharma (BBIO) Receives Positive Analyst Coverage from RBC Capital

Apr 10, 2026

Please enable cookies. You are unable to access gurufocus.com Why have I been blocked? This website is using…

Read more
optimumbank-holdings,-inc.-announces-initiation-of-coverage-by-alliance-global-partners

OptimumBank Holdings, Inc. Announces Initiation of Coverage by Alliance Global Partners

Apr 10, 2026

This section contains press releases and other materials from third parties (including paid content). The Globe and Mail…

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 14
  6. 15
  7. 16
  8. 17
  9. 18
  10. 19
  11. 20
  12. ...
  13. 405
  14. »

Posts pagination

Newer posts Page 1 … Page 17 … Page 405 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.